Sanofi India share news, announcements and annual reports
NSE: SANOFIBSE: 500674Pharmaceuticals & BiotechnologySmall Cap
Share price at the NSE close on 30 Oct 2026. Previous close ₹3,189.50.
30 Oct: open ₹3,265.00, high ₹3,422.60, low ₹3,175.10
- Market capMarket capitalisation. Share price times the number of shares: what the whole company is worth at the day's price. The rank is by average market value over the six months to Jun 2026, among listed companies. Market capitalisation: how it is worked out
- ₹7,379 Cr614th largest listed
- P/EPrice to earnings, trailing. Market cap divided by the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, after the share of the other owners of its subsidiaries: what investors pay for each rupee of a year's profit. Price to earnings, trailing: how it is worked out
- 20.24
- P/BPrice to book. Market cap divided by the net worth that belongs to the company's own shareholders, its assets less everything it owes and less the other owners' share of its subsidiaries, on its latest balance sheet. Price to book: how it is worked out
- 8.93
- Dividend yieldDividend yield. Dividends paid per share in the twelve months to the day, as a percentage of the day's share price.
- 3.84%
- ROEReturn on equity. Profit over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, as a percentage of their net worth, the money they have in the business. Net worth is the average of the latest balance sheet and the one a year before it.
- 45.3%
- ROCEReturn on capital employed. Operating profit after depreciation (revenue less operating expenses and depreciation, without other income and one-off items) as a percentage of all the money the business runs on: the whole group's net worth, the other owners of its subsidiaries included, plus borrowings. Lease liabilities are not counted: the results filings do not state them. The profit is over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly); net worth and borrowings are on the latest balance sheet.
- 57.3%
- Debt to equityDebt to equity. Borrowings divided by the whole group's net worth, the other owners of its subsidiaries included: rupees borrowed for each rupee of equity in the business. Lease liabilities are not counted: the results filings do not state them. From the balance sheet at the end of Jun 2026.
- 0.00
- Volume, NSEVolume. Shares traded on the last trading day; delivery is the part buyers kept rather than sold again the same day. Volume in the glossary
- 2,04,44220.0% delivered
Sanofi India results
92 filed, newest first. Page 1 of 2.
Oct 2026
Aug 2026
4 Aug · Results
Apr 2026
28 Apr · Results
Feb 2026
25 Feb · Results
Oct 2025
29 Oct · Results
Jul 2025
31 Jul · Results
May 2025
14 May · Results
Feb 2025
27 Feb · Results
Nov 2024
7 Nov · Results
Jul 2024
26 Jul · Results
May 2024
13 May · Results
Feb 2024
23 Feb · Results
Nov 2023
8 Nov · Results
Aug 2023
10 Aug · Results
May 2023
10 May · Results
Feb 2023
23 Feb · Results
Apr 2022
26 Apr · Results
Feb 2022
24 Feb · Results
Oct 2021
26 Oct · Results
Jul 2021
27 Jul · Results
Apr 2021
27 Apr · Results
Feb 2021
23 Feb · Results
Oct 2020
28 Oct · Results
Jul 2020
28 Jul · Results
May 2020
19 May · Results
Feb 2020
25 Feb · Results
Nov 2019
13 Nov · Results
Jul 2019
29 Jul · Results
May 2019
8 May · Results
Feb 2019
27 Feb · Results
Nov 2018
1 Nov · Results
Jul 2018
26 Jul · Results
May 2018
8 May · Results
Feb 2018
22 Feb · Results
Oct 2017
31 Oct · Results
Jul 2017
19 Jul · Results
May 2017
5 May · Results
Feb 2017
27 Feb · Results
Nov 2016
7 Nov · Results
Jul 2016
Apr 2016
Feb 2016
Oct 2015
Jul 2015
21 Jul · Results
Apr 2015
Feb 2015
Nov 2014
Jul 2014
23 Jul · Results